1. WT Clark - May 30, 2011

   I can’t stand Pepsi anyway.

2. Glenda - August 22, 2011

   what sick companys wont buy nothing from them nothing,and telling others they our stopeing..Pepsi,Kraft,Nestle,evil,evil,evil

3. Concerned Mom - December 10, 2011

   I’m totally behind this boycott of Pepsi, Kraft, and Nestle. However, I am wondering if there is any way to tell which store brands are produced by Pepsi, Kraft, and Nestle. (Most store brands/generics are “brand name” products just in different packaging – for instance, at King Soopers in Colorado the store brand yogurt is/was produced by Dannon). It will do no good if the substitutes we purchase are produced by the same companies.

4. Amy - June 10, 2013

   These disgusting additives very likely have human DNA included-as 70 of 77 or so of these Senomyx patents for these products do. I have researched this in some detail. These companies own so much of the marketplace including Quaker and General Mills products it is not even funny.

   Current label laws allow these to be listed under “artificial flavors”.

   A current law is being looked at by the FDA to add this to all US dairy with no oversight or label of any type.

   Please see the links below to help fight this sickness/Upton Sinclair is rolling in his grave.

   Please look at all products such as Pepsi, Nestle and more whom have been utilizing new flavor additives likely derived from human aborted fetal tissues, per their own patents, as can be viewed below from their known supplier Senomyx’s patents.

   http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&RS=%28HEK-293+AND+Senomyx%29&Refine=Refine+Search&Refine=Refine+Search&Query=Senomyx

   So far patents utilized in products seem to be for the new sugar free sodas, with modifiers using GMO human tissues to produce extracts “enhancing” the flavor of sucralose, aspartame, and in the works, Stevia, Corn Syrup, and Sucrose.

   By all means this does not mean these are the only products they supply, as Senomyx also does MSG style flavor enhancers as well made from human cell tissue lines. This issue also appears to not have received the attention in deserves from the worlds kosher authorities.

   Despite reps from these companies being either silent or in denial of their products being linked, they clearly have been a supplier of these companies even per their official Nasdaq reports(link shown below),

   Read more: http://www.nasdaq.com/aspx/call-transcript.aspx?StoryID=1277531&Title=senomyx-s-ceo-discusses-q4-2012-results-earnings-call-transcript#ixzz2VA6bX5lj
   http://www.nasdaq.com/aspx/call-transcript.aspx?StoryID=1277531&Title=senomyx-s-ceo-discusses-q4-2012-results-earnings-call-transcript

   Pepsi and Nestle in particular are utilizing these additives, and Coke is newly using them as well.

   S6973 is the name for the “sweetener” in question which is only required to be listed on food labels as “ artificial flavoring. It is the written goal of Senomyx to be eventually listed as “Natural Flavors “ on labels.

   Several key points are shown through their recent SEC filing including that these are being used for both diet and non-diet products :

   “PepsiCo. In August 2010 the Company entered into a collaboration agreement with PepsiCo. The agreement relates to a four-year research program to discover and develop (1) novel natural and artificial flavor ingredients intended to modify the sweet taste of sucrose and fructose, including high fructose corn syrup, and (2) natural high intensity sweeteners, in each case for use in non-alcoholic beverage product categories on a worldwide basis. Under the agreement, the Company received an upfront payment of $30.0 million from PepsiCo, $7.5 million of which was paid in the second quarter of 2010 in connection with the signing of a letter agreement between the parties and $22.5 million of which was paid in the third quarter of 2010. Senomyx is recognizing this upfront payment over the four-year research period of the agreement. The Company is entitled to $32.0 million in committed research and development payments, payable in equal quarterly installments over the four-year research period. The Company is also entitled to milestone payments and reimbursement of certain out-of-pocket expenses. Upon commercialization, the Company is entitled to minimum annual royalties and royalty payments on products that incorporate selected flavor ingredients and/or natural high intensity sweeteners. PepsiCo has the option to extend one or more of the research programs for two additional years, which would result in additional research funding commitments and payments during the extension of the research program.”
   “We have historically derived our revenues from collaborative agreements. We license our flavor ingredients to our collaborators on an exclusive or co-exclusive basis, which we believe will provide these companies with a competitive advantage. We currently have collaborative agreements with several of the world’s leading packaged food, beverage and ingredient companies, including Ajinomoto Co., Inc., or Ajinomoto, Firmenich SA, or Firmenich, Nestlé SA, or Nestlé, and PepsiCo, Inc., or PepsiCo. Depending upon the collaboration, our collaboration agreements generally provide for license fees, research and development funding, reimbursement of certain costs, milestone payments based upon our achievement of research or development goals and, in the event of commercialization, commercial milestones, minimum periodic royalties and royalties on sales of products incorporating our flavor ingredients.”
   Flavor Ingredient Product Category License Partner Sales Model
   New sweet modifiers Non-alcoholic beverages Exclusive PepsiCo Retail
   Sucrose modifier (S6973) All foods and certain selected beverages Exclusive Firmenich Ingredient supply
   Sucrose modifier (S9632) All foods and co-exclusive in powdered beverages Exclusive Firmenich Ingredient supply
   Sucrose modifier (S9632) Non-alcoholic beverages and co-exclusive in powdered beverages None None Direct sales
   Sucralose modifier (S2383) All foods and beverages Exclusive Firmenich Ingredient supply
   New sweet modifiers All foods and co-exclusive in powdered beverages Exclusive Firmenich Ingredient supply
   New natural sweeteners Non-alcoholic beverages Exclusive PepsiCo Ingredient supply
   New natural sweeteners All foods None None or future licensee Potential direct sales

   Savory Flavor Program

   Our Savory Flavor Program is aimed at developing flavor ingredients that address a worldwide market for monosodium glutamate (MSG) of $6.3 billion at a volume of 2,600 metric tons, based on 2011 data from Pearson Sales Company and Ajinomoto’s Market and Other Information.

   Flavor Ingredient Product Category License Partner Sales Model
   Savory flavor (S336) Certain product categories and geographies per agreement Exclusive Nestlé Ingredient supply
   Savory flavors (S336, S5456) Virtually all product categories in Asia Exclusive Undisclosed Retail & Ingredient supply
   Savory flavor (S336) All product categories in North America None None or future licensee Potential direct sales
   Savory flavor (S5456) All product categories outside of Asia None None or future licensee Potential direct sales
   Savory flavor (S9229) All product categories worldwide None None or future licensee Potential direct sales

   Link:
   http://www.sec.gov/Archives/edgar/data/1123979/000110465913020884/a13-1314_110k.htm

   http://www.foodnavigator-usa.com/Suppliers2/Senomyx-granted-US-patent-for-sucralose-enhancer

   More Details

   What Senomyx is up to
   Is this claim true? Neither Pepsi nor Senomyx returned calls, so we don’t know the companies’ side of the story. But a perusal of Senomyx’s patents suggests that it may well be. All but 7 of the company’s 77 patents refer to the use of HEK 293 (human embryonic kidney) cells, which researchers have used for decades as biological workhorses. (For the bio-geeks among you, these cells offer a reliable way to produce new proteins via genetic engineering.)
   So far patents utilized in products seem to be for the new sugar free sodas, with modifiers using GMO human tissues to produce extracts “enhancing” the flavor of sucralose, aspartame, and in the works, Stevia.

   http://www.foodnavigator-usa.com/Suppliers2/Senomyx-granted-US-patent-for-sucralose-enhancer

   “California-based flavor development firm Senomyx has been granted a US patent for a sucralose enhancer, which it says can be used to cut the amount of sucralose in products by up to 75 percent
   So far, researchers using aborted fetal cell lines haven’t been able to cure paralysis or reverse the effects of Parkinson’s disease, but they may be able to make diet sodas taste better.
   PepsiCo has come under intense pressure from pro-life groups for contracting with Senomyx Inc., a San Diego biotech company accused of developing flavor enhancers using cell lines taken from the kidney of an aborted fetus. PepsiCo, the world’s second-largest food and beverage business , announced the $30 million deal on its website in August 2010.
   The move represents what pro-life advocates describe as a troubling shift in commercial research involving cell lines developed from aborted embryos and fetuses. While research has centered on vaccines and medicines, Senomyx has contracted with companies that make soft drinks, candy, gum and coffee creamers.
   After a review of Senomyx’s patents in 2011 showed that the company was using the fetal cell line in its research, more than a dozen pro-life groups launched a boycott of Pepsi products that has since spread to 11 nations, including Canada, Poland and Australia, as well as much of Western Europe.
   An attempt to bring a resolution on the issue before PepsiCo shareholders for a vote failed after the Securities and Exchange Commission ruled Feb. 28 that the research and development agreement with Senomyx fell under the category of “ordinary business operations.”
   PepsiCo attorney George A. Schieren said the proposed resolution “deals with matters related to the company’s ordinary business operations.”
   He said these operations “are so fundamental to run a company on a day-to-day basis that they could not be subject to stockholder oversight.”
   The ruling stunned pro-life advocate Debi Vinnedge, who led a similar effort in 2003 against the pharmaceutical firm Merck & Co., which uses aborted fetal cell lines in the manufacture of some vaccines. In that case, the SEC allowed the proxy vote, rejecting Merck’s “ordinary business” argument.
   “The SEC let us take Merck to task over using fetal cell lines in vaccines, so we’re shocked that the SEC would not allow it with something as simple as a flavor enhancer,” said Ms. Vinnedge, executive director of Children of God for Life, which fights the use of aborted embryonic and fetal cells in research.
   PepsiCo initially declined to comment on the issue, but in the weeks since its SEC victory, the food and beverage giant has contacted pro-life advocates and media to deny the accusations.
   Jeff Dahncke, PepsiCo senior director for communications, thanked The Washington Times in an email for “giving us the opportunity to clarify misperceptions and erroneous media reports on the topic.”
   “PepsiCo does not conduct or fund research, including research performed by third parties, that utilizes any human tissue or cell lines derived from embryos or fetuses. We clearly communicate this in our Responsible Research Statement on our website,” Mr. Dahncke’s statement said. “Any research funded by PepsiCo and conducted by Senomyx for PepsiCo must abide by this responsible research statement.”
   In a statement to LifeNews, Mr. Dahncke also denied speculation that sweeteners developed by Senomyx had been used in the recipe for Pepsi NEXT, a low-calorie cola with 60 percent less sugar than a standard Pepsi. The drink is being launched this week.
   Ms. Vinnedge called the PepsiCo denial “pure deception.”
   She said she found HEK-293, a “human embryo kidney” cell line produced from an aborted fetus in the 1970s, in more than 70 Senomyx patents, all related to flavor enhancers

   Read more:

   “Oklahoma state senator Ralph Shortey said he has been researching the issue for about a year and is concerned there are no rules preventing the use of embryonic stem cells or fetal tissue in food and other products.
   He introduced the bill in order to raise public awareness and preventing companies from engaging in any such “immoral” practices in his central plains state.
   “It’s not like I think companies are chopping up foetuses and using them as ingredients in food,” Shortey said in a telephone interview.
   But Shortey alleged the patent is proof that the supplier – Senomyx – has crossed a moral line by using “kidneys from aborted foetuses” as “taste receptors” to see how the cells respond to different artificial flavoring.
   “How ethical is it to use what I consider a destroyed human life to make food taste better,” he said.”

   http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=10781597

   http://www.lifesitenews.com/news/obama-agency-rules-pepsi-use-of-aborted-fetus-is-ordinary-business
   http://www.lifesitenews.com/images/pdfs/fetalproductsall.pdf
   http://www.cbsnews.com/8301-505123_162-44043220/pepsis-bizarro-world-boycotted-over-embryonic-cells-linked-to-lo-cal-soda/?tag=mncol;lst;1
   http://www.lifesitenews.com/blog/ocean-spray-tropicana-gatorade-also-on-list-of-products-using-aborted-fetal
   http://blogs.miaminewtimes.com/shortorder/2011/03/are_aborted_fetus_cells_helpin.php

   http://www.healthy-holistic-living.com/flavor-technology.html#ixzz11agzl1RX

Leave a Reply